These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Listed as ongoing, but also has a completion date and reported results 2004-002015-86 Calcipotriol plus Betamethasone Dipropionate Gel Compared to Betamethasone Dipropionate in the Gel Vehicle, Calcipotriol in the Gel Vehicle and the Gel Vehicle alone in Scalp Psoriasis. 2005-09-08 bad-data
Ongoing, reported early 2004-002152-33 Calcipotriol plus Betamethasone Dipropionate Gel Compared to Betamethasone Dipropionate in the Gel Vehicle and Calcipotriol in the Gel Vehicle in Scalp Psoriasis. A phase III study comparing a gel con... not-yet-due
Reported results 2004-002687-14 Fucidin® Cream in the Treatment of Impetigo A phase IV study comparing clinical and bacteriological efficacy of Fucidin® cream with Fucidin® cream vehicle in the treatment of impetigo in paediatric pa... 2005-03-11 due-trials
Reported results 2004-002861-19 Long-term treatment of Scalp Psoriasis with Calciptriol plus Betamethasone dipropionate gel. A phase III safety study of a new gel containing calcipotriol 50mcg/g plus betamethasone 0.5 mg/g (as dipro... 2006-09-22 due-trials
Listed as ongoing, but also has a completion date and reported results 2004-004577-28 Different treatment regimens of calcipotriol cream and combination (calcipotiol/betamethasone dipropionate) ointment in psoriasis vulgaris 2005-12-01 bad-data
Listed as ongoing, but also has a completion date and reported results 2005-002270-29 Safety profile of innohep versus subcutaneous unfractionated Heparin in elderly patients with impaired renal function treated for acute deep vein thrombosis 2008-04-08 bad-data
Reported results 2005-002864-27 Calcipotriol plus Betamethasone Dipropionate Gel Compared to DAIVONEX/DOVONEX Scalp Solution in Patients with Scalp Psoriasis. A phase III study comparing a gel containing calcipotriol 50 mcg/g plus b... 2006-05-17 due-trials
Listed as ongoing, but also has a completion date and reported results 2005-003215-78 Calcipotriol plus Betamethasone Dipropionate Gel Compared to Betamethasone Dipropionate in the Gel Vehicle, Calcipotriol in the Gel Vehicle and the Gel Vehicle alone in Psoriasis Vulgaris. 2006-05-03 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-001472-20 LEO19123 Cream in the Treatment of Atopic Dermatitis 2007-08-24 bad-data
Ongoing, reported early 2006-002686-39 LEO19123 Cream in the Treatment of Hand Eczema not-yet-due
Listed as ongoing, but also has a completion date and reported results 2006-002873-35 Exploratory efficacy and safety, pharmacokinetics and dose-finding study of ATryn® (antithrombin alfa) in patients with disseminated intravascular coagulation associated with severe sepsis 2009-03-18 bad-data
Listed as ongoing, but also has a completion date and reported results 2007-003365-41 Calcipotriol Plus Hydrocortisone Ointment Compared with Tacalcitol Ointment in Patients with Psoriasis Vulgaris on the Face and on the Intertriginous Areas. A phase 3 study comparing an ointment conta... 2009-06-18 bad-data
Listed as ongoing, but also has a completion date and reported results 2007-004782-18 Calcipotriol Plus Hydrocortisone in Psoriasis Vulgaris on the Face and on the Intertriginous Areas. A phase 3 study comparing an ointment containing calcipotriol 25 mcg/g plus hydrocortisone 10 mg/g ... 2010-01-11 bad-data
Ongoing, reported early 2007-005463-10 A plaque test comparing three marketed products and two products in development and a vehicle control for the treatment of psoriasis vulgaris not-yet-due
Listed as ongoing, but also has a completion date and reported results 2007-005501-22 Effect of Calcipotriol Plus Hydrocortisone Ointment on the HPA Axis and Calcium Metabolism in Patients with Psoriasis Vulgaris on the Face and on the Intertriginous Areas 2009-12-08 bad-data
Ongoing, reported early 2008-005456-24 Safety and Efficacy of Calcipotriol plus Betamethasone Dipropionate Gel in Adolescent Patients (Aged 12 to 17 Years) with Scalp Psoriasis not-yet-due
Ongoing, reported early 2008-005487-13 A plaque test comparing 4 steroids with Daivobet® ointment and a vehicle control for the treatment of psoriasis vulgaris not-yet-due
Listed as ongoing, but also has a completion date and reported results 2009-010963-18 A phase 3 study comparing an ointment containing calcipotriol 25 mcg/g plus hydrocortisone 10 mg/g (LEO 80190 ointment) with hydrocortisone 10 mg/g ointment, both applied once daily in the treatment o... 2010-06-08 bad-data
Reported results 2009-013792-22 A Phase 2, proof of concept and dose finding study, investigating treatment efficacy of LEO 29102 cream (2.5 mg/g, 1.0 mg/g, 0.3 mg/g, 0.1 mg/g, 0.03 mg/g), LEO 29102 cream vehicle, and Elidel (Pimecr... 2010-06-30 due-trials
Ongoing, reported early 2009-017858-12 A phase 2a proof of concept study comparing three doses of an oral solution of LEO 22811 with a placebo oral solution for the treatment of psoriasis vulgaris not-yet-due
Reported results 2009-018141-20 A Phase 3 Study of Subcutaneous Innohep 20,000 anti-Xa IU/ml for the Treatment of Venous Thromboembolism (VTE) in Cancer Patients 2014-06-25 due-trials
Completed, but no date 2010-021941-38 LEO 90110 ointment in the treatment of psoriasis vulgaris bad-data
Listed as ongoing, but also has a completion date and reported results 2011-005018-13 Ingenol Mebutate Gel, 0.015% Repeat Use for Multiple Actinic Keratoses on Face and Scalp 2014-02-04 bad-data
Reported results 2011-006275-20 A phase II exploratory study evaluating the efficacy of topical cromoglicate solution(20mg/ml) compared to topical solution vehicle in the treatment of mastocytosis 2013-03-05 due-trials
Reported results 2012-000253-30 An exploratory study evaluating the efficacy of cromoglicate cream compared to cream vehicle in the treatment of itch in psoriasis 2013-04-11 due-trials
Reported results 2012-002863-88 A Simultaneous Treatment Regimen Compared to a Sequential Treatment Regimen with Ingenol Mebutate Gel 0.015% and 0.05% of Two Areas with Actinic Keratosis on Face/Scalp and Trunk/Extremities 2014-01-22 due-trials
Ongoing 2012-003112-31 Risk of Squamous Cell Carcinoma on Skin Areas Treated with Ingenol Mebutate Gel, 0.015% and Imiquimod Cream, 5% not-yet-due
Reported results 2013-000410-38 Topical Aprepitant in Prurigo Patients (iTAPP) 2014-07-28 due-trials
Listed as ongoing, but also has a completion date and reported results 2013-001538-16 Effect of Calcipotriol plus Betamethasone Dipropionate Gel on the HPA Axis and Calcium Metabolism in Adolescent Subjects (Aged 12 to 16 Years, 11 months) with Scalp and Body Psoriasis 2018-02-13 bad-data
Ongoing, reported early 2013-004686-14 LEO 90100 aerosol foam compared to calcipotriol plus betamethasone dipropionate gel in subjects with psoriasis vulgaris not-yet-due
Reported results 2014-000037-23 Clinical Study Protocol 2015-03-06 due-trials
Reported results 2014-003072-24 Patient insights following use of LEO 90100 aerosol foam and Daivobet® gel in subjects with psoriasis vulgaris 2015-11-30 due-trials
Listed as ongoing, but also has a completion date and reported results 2014-003218-98 Efficacy and safety of ingenol mebutate gel 0.015% compared to diclofenac sodium gel 3% in subjects with actinic keratoses on the face or scalp. 2016-07-13 bad-data
Reported results 2014-004465-24 Safety and efficacy of repeat use of Picato® 0.05% in the treatment of anogenital warts 2015-11-26 due-trials
Ongoing, reported early 2014-004759-30 A psoriasis plaque test trial with LP0113 spray in patients with psoriasis vulgaris not-yet-due
Completed, reported early 2015-000839-33 Safety and Effect of LEO 90100 aerosol foam on the HPA Axis and Calcium Metabolism in Adolescent Subjects (Aged 12 to < 17 Years) with Plaque Psoriasis 2018-03-28 not-yet-due
Ongoing, reported early 2015-001798-41 A psoriasis plaque test trial with LEO 90100 compared to Betesil® in patients with psoriasis vulgaris not-yet-due
Reported results 2015-002098-40 A Phase 2a, Proof of Concept Trial, testing twice daily application of LEO 124249 ointment 30mg/g in the treatment of mild to moderate inverse psoriasis 2016-09-19 due-trials
Ongoing 2015-002449-71 Efficacy and Safety of LEO 43204 in Field Treatment of Actinic Keratosis on Face or Chest including 12-month follow-up not-yet-due
Reported results 2015-002450-12 Efficacy and Safety of LEO 43204 in Field Treatment of Actinic Keratosis on Face or Chest including 12-month follow-up 2017-08-10 due-trials
Ongoing 2015-002451-10 Efficacy and Safety of LEO 43204 in Field Treatment of Actinic Keratosis on Balding Scalp including 12-month follow-up not-yet-due
Completed, report not yet due 2015-002452-27 Efficacy and Safety of LEO 43204 in Field Treatment of Actinic Keratosis on Balding Scalp including 12-month follow-up 2017-10-27 not-yet-due
Reported results 2015-005279-25 LEO 32731 for the Treatment of Moderate to Severe Psoriasis Vulgaris 2017-07-06 due-trials
Ongoing 2016-000556-95 LEO 90100 twice weekly maintenance regimen for psoriasis vulgaris not-yet-due
Ongoing 2016-003867-21 A phase 4 trial comparing the efficacy of subcutaneous injections of brodalumab to oral administrations of fumaric acid esters in adults with moderate to severe plaque psoriasis not-yet-due
Ongoing 2016-004200-65 A randomised, double-blind, placebo-controlled, phase 3 trial to evaluate the efficacy and safety of tralokinumab monotherapy in subjects with moderate to severe atopic dermatitis who are candidates f... not-yet-due
Ongoing 2016-004201-13 A randomised, double-blind, placebo-controlled, phase 3 trial to evaluate the efficacy and safety of tralokinumab monotherapy in subjects with moderate to severe atopic dermatitis who are candidates f... not-yet-due
Completed, report not yet due 2017-000228-85 Incidence of squamous cell carcinoma and other skin neoplasia in subjects with actinic keratosis treated with ingenol disoxate gel 0.018% or 0.037%, or vehicle 2018-01-31 not-yet-due
Ongoing 2017-002065-21 A randomised, double-blind, placebo-controlled, phase 3 trial to evaluate the efficacy and safety of tralokinumab in combination with topical corticosteroid in subjects with moderate-to-severe atopic ... not-yet-due
Completed, report not yet due 2017-002720-24 Efficacy of twice daily application of LEO 124249 ointment 30 mg/g for 12 2018-05-16 not-yet-due
Completed, report not yet due 2017-004508-23 Capture of LEO 90100 medication usage with digital tracker and evaluation of efficacy in patients with psoriasis 2018-06-11 not-yet-due
No trial status on register 2017-005143-33 A randomised, double-blind, placebo-controlled, parallel-group, multi-centre trial to evaluate the efficacy, safety, and tolerability of tralokinumab monotherapy in adolescent subjects with moderate-t... bad-data